Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Article · Originalarbeit

Open Access Gateway

Metabolic and Psychological Response to 7-Day Fasting in Obese Patients with and without Metabolic Syndrome

Li C.a, b · Ostermann T.c · Hardt M.d · Lüdtke R.e · Broecker-Preuss M.f · Dobos G.d · Michalsen A.b, g

Author affiliations

a Department of Traditional Chinese Medicine, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China b Institute of Social Medicine, Epidemiology, and Health Economics, Charité - Universitätsmedizin Berlin, c University of Witten/Herdecke, Center for Integrative Medicine, Herdecke, d Department of Complementary and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, e Karl and Veronica Carstens Foundation, Essen, f Department of Endocrinology and Division of Laboratory Research, University Hospital of Essen, University of Duisburg-Essen, g Department of Internal and Complementary Medicine, Immanuel Hospital Berlin, Germany

Corresponding Author

Andreas Michalsen, MD, PhD

Zentrum für Naturheilkunde, Immanuel Krankenhaus Berlin

Am kleinen Wannsee 5, 14106 Berlin, Germany

a.michalsen@immanuel.de

Related Articles for ""

Forsch Komplementmed 2013;20:413-420

Do you have an account?

Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



Abstract

Background: Extended modified fasting is a frequently practiced tradition in Europe. It is claimed to improve the cardiometabolic state and physical and psychological well-being by an evolutionary co-developed adaptation response. We aimed to investigate the cardiometabolic and psychological effects of a 7-day fast and differences of these responses between patients with or without metabolic syndrome (MetS). Methods: We investigated 30 female subjects (49.0 ± 8.1 years, BMI 30.4 ± 6.7 kg/m2) with (n = 12) and without (n = 18) MetS. All subjects participated in a 7-day fast according to Buchinger with a nutritional energy intake of 300 kcal/day and stepwise reintroduction of solid food thereafter. Outcomes were assessed baseline and after fasting and included measures of metabolic and glucoregulatory control, adipokines as well as psychological well-being as assessed by Profile of Mood States (POMS) and Hospital Anxiety and Depression Scale (HADS). Results: Mean weight decreased from 85.4 ± 18.8 kg to 79.7 ± 18.2 kg accompanied by systolic/diastolic blood pressure (BP) reduction of -16.2 mm Hg (95% CI: -9.1; -23.3 mm Hg) and -6.0 mm Hg (95% CI: -1.8; -10.3 mm Hg), each p < 0.001 and p = 0.005. Fasting led to marked decreases of levels of LDL-cholesterol, leptin, and insulin and increases of levels of adiponectin, leptin receptors, and resistin. Fasting-induced mood enhancement was reflected by decreased anxiety, depression, fatigue, and improved vigor. Patients with MetS showed some greater changes in B P, LDL-cholesterol, triglycerides, adiponectin, leptin, and sleep quality. Fasting was well-tolerated. Conclusions: Our results point to marked beneficial responses to 7-day modified fasting and a potential role in the prevention of the MetS. Randomized trials with longer observation periods should test the clinical effectiveness of fasting in metabolic diseases.

© 2014 S. Karger GmbH, Freiburg


References

  1. Meshkani R, Adeli K: Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem 2009;42:1331-1346.
  2. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the Third national Health and Nutrition Examination Survey. JAMA 2002;287:356-359.
  3. Redon J, Cifkova R, Laurent S, Nilsson P, Narkiewicz K, Erdine S, Mancia G; Scientific Council of the European Society of Hypertension: The metabolic syndrome in hypertension: European Society of Hypertension position statement. J Hypertens 2008;26:1891-1900.
  4. Lafortuna CL, Adorni F, Agosti F, De Col A, Sievert K, Siegfried W, Sartorio A: Prevalence of the metabolic syndrome among extremely obese adolescents in Italy and Germany. Diabetes Res Clin Pract 2010;88:14-21.
  5. Mattson MP, Wan R: Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. J Nutr Biochem 2005;16:129-137.
  6. Michalsen A: Prolonged fasting as a method of mood enhancement in chronic pain syndromes: a review of clinical evidence and mechanisms. Curr Pain Headache Rep 2010;14:80-87.
  7. Michalsen A, Hoffmann B, Moebus S, Backer M, Langhorst J, Dobos GJ: Incorporation of fasting therapy in an integrative medicine ward: evaluation of outcome, safety, and effects on lifestyle adherence in a large prospective cohort study. J Altern Complement Med 2005;11:601-607.
  8. Hartel U, Volger E: Inanspruchnahme und Akzeptanz klassischer Naturheilverfahren und alternativer Heilmethoden in Deutschland - Ergebnisse einer repräsentativen Bevölkerungsstudie. Forsch Komplementarmed Klass Naturheilkd 2004;11:327-334.
  9. Dessi-Fulgheri P, Sarzani R, Serenelli M, Tamburrini P, Spagnolo D, Giantomassi L, Espinosa E, Rappelli A: Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives. Hypertension 1999;33:658-662.
  10. Wilhelmi de Toledo F, Gaisbauer M, Hölz G, Kronsteiner W, Kuhn C, Lischka E, Lischka N, Lützner H, May W, Melchart D, Michalsen A, Müller H, Peper E, Resch K-L, Ritzmann-Widderich M, Wessel A, Wichert H, Stange R: Leitlinien zur Fastentherapie. Forsch Komplementärmed Klass Naturheilkd 2002;9:189-198.
  11. Müller H, Wilhelmi de Toledo F, Resch KL: Fasting followed by vegetarian diet in patients with rheumatoid arthritis: a systematic review. Scand J Rheumatol 2001;30:1-10.
  12. Kjeldsen-Kragh J, Haugen M, Borchgrevink CF, Laerum E, Eek M, Mowinkel P, Hovi K, Forre O: Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet 1991;338:899-902.
  13. Müller H, Wilhelmi de Toledo F, Schuck P, Resch KL: Blutdrucksenkung durch Fasten bei Adipösen und nichtadipösen Hypertonikern. Perfusion 2001;14:108-112.
  14. Goldhamer AC, Lisle DJ, Sultana P, Anderson SV, Parpia B, Hughes B, Campbell TC: Medically supervised water-only fasting in the treatment of borderline hypertension. J Altern Complement Med 2002;8:643-650.
  15. Schubmann R: Therapeutisches Fasten bei Adipositas und metabolischem Syndrom. Z Komplementärmed 2009;1:14-17.
    External Resources
  16. Schwartz MW, Seeley RJ: Seminars in medicine of the Beth Israel Deaconess Medical Center. Neuroendocrine responses to starvation and weight loss. N Engl J Med 1997;336:1802-1811.
  17. Palmblad J, Levi L, Burger A, Melander A, Westgren U, von Schenck H, Skude G: Effects of total energy withdrawal (fasting) on the levels of growth hormone, thyrotropin, cortisol, adrenaline, noradrenaline, T4, T3 and rT3 in healthy males. Acta Med Scand 1977;201:15-22.
  18. Michalsen A, Schneider S, Rodenbeck A, Ludtke R, Huether G, Dobos GJ: The short-term effects of fasting on the neuroendocrine system in patients with chronic pain syndromes. Nutr Neurosci 2003; 6:11-18.
    External Resources
  19. Ahima RS, Lazar MA: Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol 2008;22:1023-1031.
  20. Albani C, Blaser G, Geyer M, Schmutzer G, Brahler E, Bailer H, Grulke N: The German short version of ‘Profile of Mood States' (POMS): psychometric evaluation in a representative sample (in German). Psychother Psychosom Med Psychol 2005;55:324-330.
  21. Barth J, Martin CR: Factor structure of the Hospital Anxiety and Depression Scale (HADS) in German coronary heart disease patients. Health Qual Life Outcomes 2005;3:15.
  22. Finucane FM, Luan J, Wareham NJ, Sharp SJ, O'Rahilly S, Balkau B, Flyvbjerg A, Walker M, Hojlund K, Nolan JJ; European Group for the Study of Insulin Resistance: Relationship between Insulin Sensivity and Cardiovascular Disease Risk Study Group, Savage DB: Correlation of the leptin: adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 2009;52:2345-2349.
  23. Malandrucco I, Pasqualetti P, Giordani I, Manfellotto D, De Marco F, Alegiani F, Sidoti AM, Picconi F, Di Flaviani A, Frajese G, Bonadonna RC, Frontoni S: Very-low-calorie diet: a quick therapeutic tool to improve beta cell function in morbidly obese patients with type 2 diabetes. Am J Clin Nutr 2012;95:609-613.
  24. Lützner H, Wilhelmi de Toledo F: Fasten/Fastentherapie. Physiologie des Fastens; in Bühring M, Kemper FH, Mathiessen PF (Hrsg): Naturheilverfahren und unkonventionelle medizinische Richtungen. Berlin, Springer, Loseblatt-System, 1998, pp 1-26.
  25. Steiniger J, Schneider A, Bergmann S, Boschmann M, Janietz K: Effects of fasting and endurance training on energy metabolism and physical fitness in obese patients (in German). Forsch Komplementmed 2009;16:383-390.
  26. Horne BD, May HT, Anderson JL, Kfoury AG, Bailey BM, McClure BS, Renlund DG, Lappe DL, Carlquist JF, Fisher PW, Pearson RR, Bair TL, Adams TD, Muhlestein JB: Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography. Am J Cardiol 2008;102:814-819.
  27. Oberhauser F, Schulte DM, Faust M, Gudelhofer H, Hahn M, Muller N, Neumann K, Krone W, Laudes M: Weight loss due to a very low calorie diet differentially affects insulin sensitivity and interleukin-6 serum levels in nondiabetic obese human subjects. Horm Metab Res 2012;44:465-470.
  28. Morel O, Luca F, Grunebaum L, Jesel L, Meyer N, Desprez D, Robert S, Dignat-George F, Toti F, Simon C, Goichot B: Short-term very low-calorie diet in obese females improves the haemostatic balance through the reduction of leptin levels, pai-1 concentrations and a diminished release of platelet and leukocyte-derived microparticles. Int J Obes 2011;35:1479-1486.
  29. Teeuwisse WM, Widya RL, Paulides M, Lamb HJ, Smit JW, de Roos A, van Buchem MA, Pijl H, van der Grond J: Short-term caloric restriction normalizes hypothalamic neuronal responsiveness to glucose ingestion in patients with type 2 diabetes. Diabetes 2012;61:3255-3259.
  30. Silva JP, von Meyenn F, Howell J, Thorens B, Wolfrum C, Stoffel M: Regulation of adaptive behaviour during fasting by hypothalamic Foxa2. Nature 2009;462:646-650.
  31. Gohler L, Hahnemann T, Michael N, Oehme P, Steglich HD, Conradi E, Grune T, Siems WG: Reduction of plasma catecholamines in humans during clinically controlled severe underfeeding. Prev Med 2000;30:95-102.
  32. Spark RF, Arky RA, Boulter PR, Saudek CD, O'Brian JT: Renin, aldosterone and glucagon in the natriuresis of fasting. New Engl J Med 1975; 292:1335-1340.
  33. Maoz E, Shamiss A, Peleg E, Salzberg M, Rosenthal T: The role of atrial natriuretic peptide in natriuresis of fasting. J Hypertens 1992;10:1041-1044.
    External Resources
  34. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS: Role of leptin in the neuroendocrine response to fasting. Nature 1996;382:250-252.
  35. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI: Leptin modulates the t-cell immune response and reverses starvation-induced immunosuppression. Nature 1998;394:897-901.
  36. Higami Y, Pugh TD, Page GP, Allison DB, Prolla TA, Weindruch R: Adipose tissue energy metabolism: altered gene expression profile of mice subjected to long-term caloric restriction. FASEB J 2004;18:415-417.
  37. Zhu M, Miura J, Lu LX, Bernier M, DeCabo R, Lane MA, Roth GS, Ingram DK: Circulating adiponectin levels increase in rats on caloric restriction: the potential for insulin sensitization. Exp Gerontol 2004;39:1049-1059.
  38. Harvie MN, Pegington M, Mattson M P, Frystyk J, Dillon B, Evans G, Cuzick J, Jebb SA, Martin B, Cutler RG, Son TG, Maudsley S, Carlson OD, Egan JM, Flyvbjerg A, Howell A: The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes 2011;35:714-727.
  39. Imayama I, Ulrich CM, Alfano CM, Wang C, Xiao L, Wener MH, Campbell KL, Duggan C, Foster-Schubert KE, Kong A, Mason CE, Wang CY, Blackburn GL, Bain CE, Thompson HJ, McTiernan A: Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. Cancer Res 2012;72:2314-2326.
  40. Jung KJ, Lee EK, Kim JY, Zou Y, Sung B, Heo HS, Kim MK, Lee J, Kim ND, Yu BP, Chung HY: Effect of short term calorie restriction on pro-inflammatory NF-kB and AP-1 in aged rat kidney. Inflamm Res 2009;58:143-150.
  41. Kouda K, Iki M: Beneficial effects of mild stress (hormetic effects): dietary restriction and health. J Physiol Anthropol 2010;29:127-132.
  42. Scherer T, Buettner C: Yin and Yang of hypothalamic insulin and leptin signaling in regulating white adipose tissue metabolism. Rev Endocr Metab Disord 2011;12:235-243.
  43. Piaggi P, Thearle MS, Bogardus C, Krakoff J: Lower energy expenditure predicts long-term increases in weight and fat mass. J Clin Endocrinol Metab 2013;98:E703-E707.
  44. Wadden TA, Fujioka K, Toubro S, Gantz I, Erondu NE, Chen M, Suryawanshi S, Carofano W, Johnson-Levonas AO, Shapiro DR, Kaufman KD, Heymsfield SB, Amatruda JM: A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie diet. Obesity (Silver Spring) 2010;18:2301-2310.

Article / Publication Details

First-Page Preview
Abstract of Original Article <i>· </i> Originalarbeit

Published online: June 28, 2013
Issue release date: December 2013

Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 0

ISSN: 2504-2092 (Print)
eISSN: 2504-2106 (Online)

For additional information: https://www.karger.com/CMR


Open Access License / Drug Dosage / Disclaimer

Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.